« Back to Record
Wildiers, H., Cardoso, F., Brain, E., Tryfonidis, K., Dal Lago, L., Vuylsteke, P., Curigliano, G., Waters, S., Brouwers, B., Altintas, S., & Touati, N. (2018). Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet oncology, 19(3), 323-336. doi:10.1016/S1470-2045(18)30083-4
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/269542



